Gujarat Kidney And Super Speciality IPO
GMP, Subscription, Price, Dates & Financial Details
Healthcare Services
Incorporated in 2019, Gujarat Kidney & Super Speciality Limited (“GKASSL”) is a regional multispeciality healthcare provider offering secondary and tertiary care services across multiple locations in Gujarat, India. The company operates a network of multispeciality hospitals supported by…
Open Date
Mon, 22 Dec 2025
Close Date
Wed, 24 Dec 2025
Price Band
₹ 108 – 114
Lot Size
128
Issue Size
₹ 250.80 Cr
Minimum Investment
₹ 14,592 (128 Shares)
Grey Market Premium Analysis
Day Wise GMP→Unofficial premium quoted in the grey market, tracked daily against the price band cap.
Grey market trading is unregulated. GMP figures are indicative only and should not be the sole basis for investment decisions - treat as a sentiment indicator, not a guarantee.
IPO Details
Gujarat Kidney And Super Speciality IPO has successfully completed its IPO process and is now listed on the NSE and BSE. According to the Red Herring Prospectus (RHP), the IPO was a book-built issue with a total issue size of ₹250.80 Crore, comprising a fresh issue of 2.20 Crore equity shares aggregating to ₹250.80 Crore.
The Gujarat Kidney And Super Speciality IPO remained open for subscription from December 22, 2025, to December 24, 2025. The basis of allotment was finalized on December 26, 2025, and the company's shares were listed on the NSE and BSE on December 30, 2025.
The company had fixed the price band at ₹108 to ₹114 per share, with a lot size of 128 shares. Retail investors were required to make a minimum investment of ₹14,592 (based on the upper price band) to apply for one lot.
MUFG Intime India Private Limited served as the registrar to the issue. Nirbhay Capital Services Private Limited acted as the Book Running Lead Managers (BRLMs) to the issue.
With the successful completion of the IPO process, Gujarat Kidney And Super Speciality Limited is now a publicly listed company on the NSE and BSE. Investors can track the company's share price, trading performance, financial results, and corporate announcements through the stock exchanges.
Gujarat Kidney And Super Speciality IPO Timeline (Tentative)
- IPO Open Date
- Mon, 22 Dec 25
- IPO Close Date
- Wed, 24 Dec 25
- Basis of Allotment
- Fri, 26 Dec 25
- Initiation of Refunds
- Mon, 29 Dec 25
- Credit of Shares to Demat
- Mon, 29 Dec 25
- Listing Date
- Tue, 30 Dec 25 — NSE & BSE
Open Date
22 December 2025
Close Date
24 December 2025
Basis Of Allotment
26 December 2025
Listing Date
30 December 2025
IPO Subscription
Check Live Subscription →The Gujarat Kidney And Super Speciality IPO has received bids for 6,89,69,088 shares against 1,32,26,880 shares offered, resulting in an overall subscription of 5.21x. the NII category is subscribed 5.73x, Retail Investors 19.04x, and QIBs 1.06x. Within the NII category, BNII is subscribed 5.25x, while SNII is subscribed 6.68x.
QIB
1.06x
NII
5.73x
BNII
5.25x
SNII
6.68x
RII
19.04x
Total
5.21x
IPO Reservations
The Retail Individual Investor (RII) category has the highest allocation with 22,00,000 shares, representing 16.63% of the total issue. Qualified Institutional Buyers (QIBs) are allocated 77,26,880 shares (58.42%), while Non-Institutional Investors (NIIs) receive 33,00,000 shares (24.95%).
| Category | Shares Offered | Shares Offered % |
|---|---|---|
| Qualified Institutions | 7,726,880 | 58.42% |
| Non-Institutional | 3,300,000 | 24.95% |
| BNII | 2,200,000 | 16.63% |
| SNII | 1,100,000 | 8.32% |
| Retail Investors | 2,200,000 | 16.63% |
| Total | 13,226,880 | 100% |
Financials Details(₹ in Crores)
| Particular | 30 Jun 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 61.59 | 55.34 | 20.53 | 3.87 |
| Revenue | 15.27 | 40.4 | 5.48 | 0 |
| Profit After Tax | 5.4 | 9.5 | 1.71 | -0.01 |
| Net Worth | 30.56 | 25.71 | 10.8 | 0.37 |
| Reserve & Surplus | 19.42 | 14.57 | 10.6 | 0.17 |
| Total Borrowings | 4.03 | 3.88 | 1.94 | 0 |
Financials Performance
Performance Indicators
EPS Pre
Earnings per share before the IPO.
P/E Pre
IPO Offer Price ÷ EPS Pre.
EPS Post
Expected earnings per share after the IPO..
P/E (Post Issue)
IPO Offer Price ÷ EPS Post.
Gujarat Kidney And Super Speciality Limited KPI Information
| Particular | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| ROE % | 36.61 | 15.86 | -1.67 |
| ROCE % | 37.65 | 9.79 | -1.7 |
| Debt / Equity | 0.15 | 0.18 | 0 |
| RoNW % | 36.61 | 15.86 | -1.68 |
| Pat Margin % | 23.61 | 35.9 | 0 |
Peers Comparison
| Company | Face Value | PE Ratio | EPS Basic | EPS Diluted | RoNW | Net Assets |
|---|---|---|---|---|---|---|
| Gujarat Kidney & Super Speciality Ltd | 2 | 0.00 | 1.85 | 1.85 | 36.61 | 5.04 |
| Yatharth Hospital & Trauma Care Services Ltd | 10 | 55.84 | 14.72 | 14.72 | 8.13 | 166.62 |
| GPT Healthcare Ltd | 10 | 24.51 | 6.08 | 6.08 | 20.14 | 30.21 |
| KMC Speciality Hospitals (India) Ltd | 1 | 52.60 | 1.31 | 1.31 | 13.04 | 10.08 |
About Gujarat Kidney And Super Speciality Limited
Incorporated in 2019, Gujarat Kidney & Super Speciality Limited (“GKASSL”) is a regional multispeciality healthcare provider offering secondary and tertiary care services across multiple locations in Gujarat, India. The company operates a network of multispeciality hospitals supported by in-house pharmacy and diagnostic services, catering to both private patients and beneficiaries under government healthcare schemes such as Ayushman Bharat – PMJAY.
As of June 30, 2025, GKASSL operated seven multispeciality hospitals and four pharmacies with an aggregate infrastructure of 490 total beds, including 455 approved beds and 340 operational beds. Its hospital network includes Gujarat Kidney and Superspeciality Hospital (Vadodara), Gujarat Multispeciality Hospital (Godhra), Raj Palmland Hospital Private Limited (Bharuch), Surya Hospital and ICU (Borsad), Gujarat Surgical Hospital (Vadodara), Ashwini Medical Centre (Anand), along with Ashwini Medical Store (Anand).
The company provides a comprehensive range of medical services spanning:
- Secondary Care Services: General medicine and general surgical treatments
- Tertiary Care Services: Super speciality surgical procedures
Gujarat Superspeciality Hospital delivers care across multiple clinical disciplines, including internal medicine, general and minimally invasive surgery, orthopaedics and trauma care, joint replacement, obstetrics and gynaecology, respiratory care, non-interventional cardiology, diabetology, and anaesthesiology.
As of June 30, 2025, the company employed 759 personnel, comprising 89 doctors, 332 nurses, and 338 other staff members.
Competitive Strengths
- Established presence in renal sciences with sub-superspeciality expertise in urology
- Asset-light operating model with a strategic focus on central Gujarat
- Ability to attract and retain skilled and experienced medical professionals
- Proven track record of operational scale-up and financial growth
As of March 20, 2025, Gujarat Kidney & Super Speciality operated six multispeciality hospitals and three in-house pharmacies across Vadodara, Godhra, Bharuch, Borsad, and Anand, with consolidated infrastructure of 400 total beds, including 355 approved beds and 250 operational beds. The workforce at that time comprised 322 personnel, including 47 doctors, 138 nurses, 21 full-time consultants, and 32 visiting consultants.
In line with its expansion strategy, the company is acquiring Parekhs Hospital, Ahmedabad—a 49-bed facility (including 8 ICU beds) commissioned in 2006—for ₹77 crore, funded through net proceeds, further strengthening its footprint in Gujarat’s underpenetrated healthcare markets.
Gujarat Kidney And Super Speciality IPO Promoters
- Dr. Pragnesh Yashwantsinh Bharpoda
- Dr. Bhartiben Pragnesh Bharpoda
- Dr. Yashwantsingh Motisinh Bharpoda
- Anitaben Yashwantsinh Bharpoda
Promoters Holding
Holding Pre Issue
99.10%
Holding Post Issue
71.45%
Gujarat Kidney And Super Speciality IPO Objective
The Company Gujarat Kidney And Super Speciality IPO proposes to utilise the Net Proceeds from the Issue towards the following objects.
- Proposed acquisition of Parekhs Hospital at Ahmedabad
- Part-payment of purchase consideration for the already acquired “Ashwini Medical Centre”
- Funding of capital expenditure requirements of our Company towards setting up of a new hospital in Vadodara
- Buying robotics equipment for our hospital Gujarat Kidney & Super Speciality hospital at Vadodara location
- Full or part repayment and/or prepayment of certain outstanding secured borrowings availed by our Company
- Funding inorganic growth through unidentified acquisitions and General Corporate Purposes
Gujarat Kidney And Super Speciality Limited Address / Contact Details
Gujarat Kidney & Super Speciality Limited
Plot No. 1, City Sarve No. 1537/A,
Jetalpur Road, Gokak Mill Compound,
Alkapuri, Vadodara , Gujarat, India
Vadodara, Gujarat, 390020
Phone: +91 265 298 48
Email: info@gujaratsuperspecialityhospital.com
IPO Snapshot
Gujarat Kidney And Super Speciality IPO Lot Size
The Gujarat Kidney And Super Speciality IPO has a lot size of 128 shares. Retail investors require a minimum investment of ₹14,592 by applying for 1 lot (128 shares). The maximum application allowed for the retail category is 13 lots (1,664 shares), requiring an investment of ₹1,89,696.
| Application | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 128 | 14,592.00 |
| Retail (Max) | 13 | 1,664 | 189,696.00 |
| S-HNI (Min) | 14 | 1,792 | 204,288.00 |
| S-HNI (Max) | 68 | 8,704 | 992,256.00 |
| B-HNI (Min) | 69 | 8,832 | 1,006,848.00 |
Issue Reservation
- QIB — 58.42%
- NII — 24.95%
- RII — 16.63%
Gujarat Kidney And Super Speciality IPO Registrar
MUFG Intime India Private Limited
Check Allotment StatusBook Running Lead Managers
- Nirbhay Capital Services Private Limited
IPO Documents & Links
Explore More IPOs
Currently Open
Coming Up Next
Disclaimer: This data is for informational purposes only and does not constitute investment advice.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
What is the Gujarat Kidney And Super Speciality IPO?
Gujarat Kidney And Super Speciality IPO is a Book-building IPO with a total issue size of ₹250.8 crore. The Gujarat Kidney And Super Speciality IPO price band is ₹108 to 114 per share. The Gujarat Kidney And Super Speciality IPO subscription opens on Mon, Dec 22, 2025, and closes on Wed, Dec 24, 2025. The Gujarat Kidney And Super Speciality IPO will be listed on the BSE,NSE. MUFG Intime India Private Limited is the registrar for the Gujarat Kidney And Super Speciality IPO.
When will the Gujarat Kidney And Super Speciality IPO open for subscription?
The Gujarat Kidney And Super Speciality IPO opens on Mon, Dec 22, 2025 and closes on Wed, Dec 24, 2025
What is Gujarat Kidney And Super Speciality IPO Price Band?
Gujarat Kidney And Super Speciality IPO Price Band is ₹108 to 114 per share.
What is Gujarat Kidney And Super Speciality IPO Lot Size?
Gujarat Kidney And Super Speciality IPO lot size is 128 shares, Retail investors need a minimum investment of ₹14592 based on the upper price band
What is the minimum investment for Gujarat Kidney And Super Speciality IPO?
The minimum investment for Gujarat Kidney And Super Speciality IPO is ₹14592, based on one lot of 128 shares at the upper price band of ₹114 per share.
How to apply for Gujarat Kidney And Super Speciality IPO?
Investors can apply for the Gujarat Kidney And Super Speciality IPO through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or through UPI using a SEBI-registered broker or trading app. Select the desired lot size, enter your bid within the price band, and submit the application before Wed, Dec 24, 2025. The application amount remains blocked until the Gujarat Kidney And Super Speciality IPO allotment is finalized.
What is Gujarat Kidney And Super Speciality IPO Issue Size?
Gujarat Kidney And Super Speciality IPO issue size is ₹250.8 crores.
What is the Gujarat Kidney And Super Speciality IPO Allotment Date?
Gujarat Kidney And Super Speciality IPO allotment date is Fri, Dec 26, 2025.
Who is the Gujarat Kidney And Super Speciality IPO Registrar?
The registrar for Gujarat Kidney And Super Speciality IPO is MUFG Intime India Private Limited. Investors can go to MUFG Intime India Private Limited website to check Gujarat Kidney And Super Speciality IPO allotment status, refund processing, and other IPO-related information.
What is the Gujarat Kidney And Super Speciality IPO GMP?
The Gujarat Kidney And Super Speciality IPO GMP (Grey Market Premium) is ₹1 as of Tue, Dec 30, 2025. Based on the upper price band of ₹114 per share, the estimated Gujarat Kidney And Super Speciality IPO listing price is ₹115, indicating a potential listing gain of approximately 0.88% over the issue price.
Who is the Gujarat Kidney And Super Speciality IPO Lead Manager?
The book-running lead managers (BRLMs) for the Gujarat Kidney And Super Speciality IPO are Nirbhay Capital Services Private Limited . The lead managers are responsible for managing the IPO process, including issue structuring, regulatory compliance, marketing the public issue, coordinating with investors, and ensuring a smooth listing process. For complete details, investors should refer to the Gujarat Kidney And Super Speciality IPO Red Herring Prospectus (RHP).